department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Hemady · pharmadog

pharmadog
drugs
Hemady

drug

patient view →

dexamethasone

Marketedupdated 2mo ago

by Fera Pharmaceuticals LLC

Approved

community read0 votes

indications

investigational

Multiple SclerosisIBD (Crohn's + UC)Rheumatoid ArthritisPsoriasisLupusAsthma

all catalysts(10)

phase 0 trial completion · 1

phase 2 completion · 7

phase 2 initiation · 1

phase iv trial initiation · 1

view all 10 catalysts →

News(0)

no news has mentioned this drug yet

brand

Hemady

generic

dexamethasone [INN]

indication

Multiple Myeloma (Kahler Disease)

phase

marketed

phase 0 trial completion

Yangzhou No.1 People's Hospital — dexamethasone (Phase 0 Trial Completion)

phase 2 completion

Nizam's Institute of Medical Sciences — dexamethasone (Phase II Trial Completion)

phase 2 completion

Assiut University — dexamethasone (Phase II Trial Completion)

phase 2 completion

BC Children's Hospital Research Institute — dexamethasone (Phase II Trial Completion)

phase 2 completion

West China Hospital of Stomatology — dexamethasone (Phase II Trial Completion)

phase 2 completion

Buddhachinaraj Hospital — dexamethasone (Phase II Trial Completion)

phase 2 completion

Dalian Municipal Central Hospital — dexamethasone (Phase II Trial Completion)

phase 2 completion

ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini — dexamethasone (Phase II Trial Completion)

phase 2 initiation

Gaziantep City Hospital — dexamethasone (Phase II Trial Initiation)

phase iv trial initiation

Jawaharlal Nehru Medical College — dexamethasone (Phase IV Trial Initiation)

Data sources

ClinicalTrials.gov

last refreshed 50m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 3, 2026

88 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

Dec 18, 2037formulationUS 10537585
Dec 18, 2037formulationUS 11304961

FDA exclusivities (1)

Oct 3, 2026ODE-271Orphan Drug (7y)88d

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying dexamethasone

phase2A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myelomaactive not recruitingn=208
phase3A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphomaactive not recruitingn=501
phase1Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myelomacompletedn=3
phase3Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Boneterminatedn=11
phase1RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancerterminatedn=15
phase2Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosisrecruitingn=53
phase3A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)active not recruitingn=281
phase3MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)recruitingn=492

more trials →